Understand the source comparison
Peptide Deals October 2026 Sales Promotions: Structural Comparison
GLP-1/GIP Receptor Agonists Survodutide, Mazdutide $195–$240 $145–$175 22–27% Highest synthesis complexity. October 2026 pricing represents rare opportunity on premium metabolic compounds that rarely see meaningful discounts Growth Hormone Secretagogues MK 677
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GLP-1/GIP Receptor Agonists
- Survodutide, Mazdutide
- $195–$240
- $145–$175
- 22–27%
- Highest synthesis complexity. October 2026 pricing represents rare opportunity on premium metabolic compounds that rarely see meaningful discounts
- Growth Hormone Secretagogues
- MK 677, Hexarelin, GHRP-2
- $125–$165
- $88–$118
- 26–29%
- Most requested category in research settings. October savings create budget extension for multi-compound comparative protocols
- Nootropic Peptides
- Cerebrolysin, Dihexa, P21
- $170–$210
- $125–$155
- 24–26%
- Cognitive research compounds with documented BDNF and synaptogenesis effects. Pricing advantage allows broader experimental design
- Immunomodulatory Sequences
- Thymalin, KPV, Cartalax
- $140–$180
- $98–$130
- 27–30%
- Thymus-derived and synthetic immune regulators. October 2026 delivers steepest percentage discounts in this category
- Regenerative/Metabolic Support
- Tesofensine, Lipo C
- $115–$145
- $82–$105
- 27–29%
- Tissue repair and lipotropic formulations. Consistent 27–29% savings across subcategory
- Experimental Analogs
- SLU-PP-332
- $185–$220
- $138–$165
- 23–25%
- Novel structures under early evaluation. Promotional pricing reduces barrier to exploratory research